Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.
Deutsch
S I
SI
Department of Psychiatry, Georgetown University School of Medicine, Washington, D.C.
Morihisa
J M
JM
D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D005971:Glutamates / Q000627:therapeutic use*; D005973:Glutamine / Q000502:physiology*; D006801:Humans
D005971:Glutamates; D005973:Glutamine